HALO logo
halo search icon
MIPH
Minapharm Pharmaceuticals

MIPH · Minapharm Pharmaceuticals

746.71

EGP
0.00 (0.00%)
23/07/2026 12:00:00 AM
+1
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

EGP8.80B

PE

14.00

EV/EBITDA

4.5

DIV Yield

1.5%

Payout Ratio

22%

MQV Rating

5Very Weak

As at 23/07/2026 12:00:00 AM

Price Chart

Description

Minapharm Pharmaceuticals engages in the manufacture and marketing of pharmaceutical products. It offers products that specialize in gastroenterology, ophthalmology, dermatology, cardiology, biogenetics and orthopedics. The company was founded by Saad El Bardissi in 1958 and is headquartered in Cairo, Egypt.

  • All-Companies
  • HALO 200
  • HALO All
  • HALO Small
  • Hammer Bearish

Key Fundamentals

EPS 3 yr Growth

-69.50%

EBITDA Margin

17.30%

Operating Cashflow

£267m

Free Cash Flow Return

4.40%

ROIC

2.10%

Interest Coverage

1.70

Quick Ratio

0.90

Performance

52 weeks range

Low 226 - 774.99

Trade Value (12mth)

US$9,101.00

1 week

3.34%

1 month

12.77%

YTD

112.59%

1 year

314.84%

All time high

774.99

Additional Data

Shares Outstanding (Fully Diluted)

11m

HALO Sector

Healthcare

Next Company Report Date

N/A

Next Ex Dividend Date

12-Aug-26

Next Dividend Pay Date

16-Aug-26

Reporting Currency

EGP

Short Sell (% of issue)

0.00

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Very Weak

Momentum

Price

Strong

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

No announcements available.

See beyond the curve.

One solution for research, investing and portfolio management.
Want to learn more?Frequently asked questions.
1
What is the current share price of Minapharm Pharmaceuticals (MIPH:CAI)?
Halo FAQ
The current share price of Minapharm Pharmaceuticals (MIPH:CAI) is EGP£746.71.
2
What is the 52-week high share price for Minapharm Pharmaceuticals (MIPH:CAI)?
Halo FAQ
The 52-week high share price for Minapharm Pharmaceuticals (MIPH:CAI) is EGP£774.99.
3
What is the 52-week low share price for Minapharm Pharmaceuticals (MIPH:CAI)?
Halo FAQ
The 52-week low share price for Minapharm Pharmaceuticals (MIPH:CAI) is EGP£226.00.
4
What is the dividend yield for Minapharm Pharmaceuticals (MIPH:CAI)?
Halo FAQ
The current TTM dividend payout for Minapharm Pharmaceuticals (MIPH:CAI) is 1.50.
5
What was Minapharm Pharmaceuticals (MIPH:CAI) last dividend payment?
Halo FAQ
The last dividend payment of Minapharm Pharmaceuticals (MIPH:CAI) is EGP£2.50.
6
What is the franking level for Minapharm Pharmaceuticals (MIPH:CAI)?
Halo FAQ
Minapharm Pharmaceuticals (MIPH:CAI) has a franking level of 0.00%.
7
In which sector is Minapharm Pharmaceuticals (MIPH:CAI) classified?
Halo FAQ
Minapharm Pharmaceuticals (MIPH:CAI) is classified in the Healthcare.
8
What is the price-to-earnings (P/E) ratio for Minapharm Pharmaceuticals (MIPH:CAI)?
Halo FAQ
The current P/E ratio for Minapharm Pharmaceuticals (MIPH:CAI) is 14.00.